WallStSmart

Alphabet Inc Class C (GOOG)vsTNL Mediagene Ordinary Shares (TNMG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Alphabet Inc Class C generates 850450% more annual revenue ($422.50B vs $49.67M). GOOG leads profitability with a 37.9% profit margin vs -167.9%. GOOG earns a higher WallStSmart Score of 75/100 (B).

GOOG

Strong Buy

75

out of 100

Grade: B

Growth: 8.7Profit: 9.5Value: 6.0Quality: 8.0
Piotroski: 4/9Altman Z: 3.91

TNMG

Avoid

30

out of 100

Grade: F

Growth: 6.7Profit: 2.0Value: 5.0Quality: 3.0
Piotroski: 4/9Altman Z: -4.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

GOOGUndervalued (+0.9%)

Margin of Safety

+0.9%

Fair Value

$369.04

Current Price

$365.76

$3.28 discount

UndervaluedFair: $369.04Overvalued

Intrinsic value data unavailable for TNMG.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GOOG6 strengths · Avg: 10.0/10
Market CapQuality
$4.34T10/10

Mega-cap, among the largest globally

Return on EquityProfitability
33.5%10/10

Every $100 of equity generates 33 in profit

Profit MarginProfitability
37.9%10/10

Keeps 38 of every $100 in revenue as profit

Operating MarginProfitability
36.1%10/10

Strong operational efficiency at 36.1%

EPS GrowthGrowth
82.0%10/10

Earnings expanding 82.0% YoY

Free Cash FlowQuality
$10.12B10/10

Generating 10.1B in free cash flow

TNMG1 strengths · Avg: 10.0/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Areas to Watch

GOOG2 concerns · Avg: 4.0/10
P/E RatioValuation
27.3x4/10

Moderate valuation

Price/BookValuation
9.3x4/10

Trading at 9.3x book value

TNMG4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$2.09M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-164.6%2/10

ROE of -164.6% — below average capital efficiency

Free Cash FlowQuality
$-3.15M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : GOOG

The strongest argument for GOOG centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 37.9% and operating margin at 36.1%. Revenue growth of 21.8% demonstrates continued momentum.

Bull Case : TNMG

The strongest argument for TNMG centers on Price/Book.

Bear Case : GOOG

The primary concerns for GOOG are P/E Ratio, Price/Book.

Bear Case : TNMG

The primary concerns for TNMG are EPS Growth, Market Cap, Return on Equity. Debt-to-equity of 23.52 is elevated, increasing financial risk.

Key Dynamics to Monitor

GOOG profiles as a growth stock while TNMG is a turnaround play — different risk/reward profiles.

GOOG carries more volatility with a beta of 1.27 — expect wider price swings.

GOOG is growing revenue faster at 21.8% — sustainability is the question.

GOOG generates stronger free cash flow (10.1B), providing more financial flexibility.

Bottom Line

GOOG scores higher overall (75/100 vs 30/100), backed by strong 37.9% margins and 21.8% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alphabet Inc Class C

COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA

Alphabet Inc. is an American multinational conglomerate headquartered in Mountain View, California. It was created through a restructuring of Google on October 2, 2015, and became the parent company of Google and several former Google subsidiaries. The two co-founders of Google remained as controlling shareholders, board members, and employees at Alphabet. Alphabet is the world's fourth-largest technology company by revenue and one of the world's most valuable companies.

Visit Website →

TNL Mediagene Ordinary Shares

COMMUNICATION SERVICES · PUBLISHING · USA

TNL Mediagene Ordinary Shares is an innovative biopharmaceutical company focused on developing and commercializing advanced medical therapies that target critical unmet needs in oncology and autoimmune disorders. The company boasts a promising pipeline supported by cutting-edge technologies and strategic collaborations, positioning it for significant growth within the competitive healthcare sector. With a strong commitment to scientific excellence and patient-centered solutions, TNL Mediagene is establishing itself as a key player in the biopharmaceutical industry, dedicated to enhancing patient outcomes and addressing challenging health issues.

Visit Website →

Want to dig deeper into these stocks?